Overview
A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
Indication
用于极严重高血压或住院不能口服药物的高血压患者初1～2天的对症处理。
Associated Conditions
- Malignant Hypertension
- Severe Hypertension
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2015/12/03 | Phase 2 | Terminated | |||
2012/09/24 | Phase 4 | UNKNOWN | University of Roma La Sapienza | ||
2011/03/28 | Not Applicable | Completed | |||
2010/02/23 | Phase 4 | Withdrawn | |||
2009/09/23 | Phase 3 | Completed | Bambino Gesù Hospital and Research Institute | ||
2008/09/05 | Phase 4 | Completed | IRCCS Policlinico S. Donato | ||
2008/08/28 | Not Applicable | Terminated | |||
2008/02/22 | Phase 3 | Completed | |||
2008/01/11 | Phase 1 | UNKNOWN | |||
2007/11/12 | Phase 3 | Terminated |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Hospira, Inc. | 0409-3373 | INTRAVENOUS | 10 mg in 1 mL | 8/10/2021 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.